Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors

C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors

US Patent 10533035 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphic forms of bictegravir potassium2025
Process for the preparation of sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6,-trifluo2024
Process for the preparation of angiotensin II receptor blockers2023
Process for the preparation of sodium (2R,5S,13AR)-7,9-dioxo-10-((2,4,6-trifluor2023
Process for the preparation of diphenylpyrazine derivatives2022
Process for the preparation of diphenylpyrazine derivatives2022
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021
C-3 novel triterpenone with C-17 reverse amide derivatives as HIV inhibitors2021